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the osteoarthritis process, on the control of TGFI~ receptor II and 
Smad7 expression in articular chondrocytes. 
Methods: Primary cultures of Human Articular Chondrocytes 
(HAC) were treated with IL-11~ and TGFI~ effect was investigated. 
TGFl~-induced gene expression was analyzed through PAl-1 and 
3TP-Lux induction and TGFI~ signaling by R-Smad phosphoryla- 
tion and I-Smad expression. Type II TGFI~ receptor (TbRII) protein 
and mRNA expression were measured by Western-Blot and real- 
time RT-PCR. Transient transfections of human TbRII promoter 
constructs were performed to delineate the DNA sequences that 
mediate the IL-11~ effect. Experiments were also performed to 
overexpress or inhibit transcription factors involved in that reg- 
ulation. 
Results: We showed that IL-11~ pretreatment inhibits TGFI~- 
induced gene expression. Moreover, IL-11~ caused a dramatic de- 
crease of TI~RII at mRNA and protein level. TGFI~ signaling was 
also affected since IL-11~ inhibits TGFl~-induced Smad2/3 phos- 
phorylation and up regulates Smad7. In addition, we showed that 
the effect of IL-1 on TI~RII gene expression was mediated through 
a minimal core promoter that contains putative binding sites for 
NF-KB, Ets and AP-4 transcription factors. Overexpression and 
inhibition of these factors suggest that they cooperate to induce 
the IL-11~ effect. 
Conclusion: IL-11~ impairs TGFI~ signaling through TI~RII down- 
regulation and Smad 7 upregulation. This could explain the re- 
duced responsiveness of articular chondrocytes to TGFI~ during 
the late stages of OA process. 
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Aim: To investigate the mechanisms associated with the syner- 
gistic stimulation of aggrecan degradation by IL-I~ and Onco- 
statin M (OSM) in human articular cartilage and to measure OSM 
levels in synovial fluids (SF) obtained from patients with joint in- 
jury or arthritis. 
Methods: Normal human articular cartilage was obtained from 
autopsy and SF were obtained with informed consent and used 
under the approval of the institutional review board. Cartilage ex- 
plants were incubated with IL-I~ (20-100 ng/ml), OSM (10-50 
ng/ml), or the combination and analyzed for aggrecan degra- 
dation. Aggrecanase production was measured using a human 
articular chondrocyte cell-based enzymatic assay and a neoepi- 
tope ELI SA. To identify specific proteases impacted by IL-1 ~ and 
OSM, human chondrocytes derived from 4 donors were used to 
examine the effects on gene expression of ADAMTS-4, ADAMTS- 
5, MMP-9, and MMP-13 by RT PCR after 6 and 24 hours. OSM 
concentrations in OA SFs were analyzed using an ELISA devel- 
oped at GSK using a monoclonal anti-human OSM. 
Results: . In human articular cartilage explants, the combina- 
tion of IL-I~ and OSM caused a synergistic stimulation of aggre- 
can degradation in a concentration dependent manner, compared 
to IL-I~ treatment alone. In a human chondrocyte-based aggre- 
canase assay, IL-I~ or OSM alone had minimal effects, but the 
combination resulted in a synergistic stimulation of aggrecanase 
production. The synergistic effects by IL-1 and OSM on both car- 
tilage aggrecan degradation and aggrecanase production were 
completely blocked by the aggrecanase inhibitor. 
I L-I~ and OSM had differential effects on protease expression. 
Both cytokines alone induced ADAMTS-4 and MMP-13 expres- 
sion. IL-I~ but not OSM induced MMP-9 expression, and neither 
had an appreciable im pact on ADAMTS-5 expression either alone 
or in combination. The combination of IL-I~ and OSM had an ad- 
ditive effect on MMP-9 and MMP-13, and caused a synergistic 
stimulation of ADAMTS4 expression. 
SFs from 46 OA subjects were analyzed using an OSM ELISA, 
and 33 SF samples had detectable levels (limit of detection: 16 
pg/ml) of OSM. Several SF samples contained OSM at high levels 
(> 200pg/ml), and OSM concentrations of > 1000 pg/ml were 
detected in three samples. 
Conclusion: Synergistic stimulation of aggrecan degradation in 
human cartilage explants by IL-I~ and OSM is associated with a 
specific and synergistic induction of ADAMTS-4. Significant levels 
of OSM were detected in several SF samples from patients with 
joint injury. Together, these data support a role for OSM in OA. 
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Purpose: OA cartilage explants spontaneously produce multi- 
ple cyclooxygenase and lipoxygenase products (including PGE2, 
PGD2, LTB4). PGE2, the predominant eicosanoid produced, sig- 
nals via four G-protein-coupled receptors (EP1 -EP4). In these 
studies we investigated the expression of EP receptors and ef- 
fects of PGE2 and the EP4 antagonist (A23858) on chondrocyte 
metabolism. 
Methods: Cartilage explants were prepared from OA patients 
undergoing joint replacement surgery. In selected experiments 
chondrocytes were isolated using collagenase digestion and cul- 
tured in alginate beads. The expression of PGE2 receptors (EPs) 
was analyzed using microarray and Real time-PCR. 
Results: Transcripts for all four EP receptors were expressed in 
both normal and OA chondrocytes. However, the EP4 receptor 
was upregulated (2-3-fold) in OA compared to normal. The addi- 
tion of PGE2 (0.1-10uM) exerted the following deleterious effects: 
1) PGE2 inhibited proteoglycan synthesis (35S incorporation) by 
chondrocyte cultures to levels of 75% control (p<0.01). The po- 
tency of inhibition was comparable to that of IL-lb, and the in- 
hibitory effects of the combination of IL-lb plus PGE2 (10uM) 
were additive; 2) PGE2 induced the production of LTB4, which 
itself exerted independent catabolic actions; 3) PGE2 induced 
the production of pro-MMP-13, IL-6 and IL-8. To examine the 
effects of endogenous PGE2 produced in response to IL-1, we 
performed experiments in the presence or absence of the COX- 
2 inhibitor, celecoxib. The addition of IL-1 reduced chondrocyte 
proteoglycan synthesis to 45% of control values; pretreatment 
with 2uM celecoxib, which inhibited IL-1 induced PGE2 produc- 
tion by >80%, reversed IL-1 dependent inhibition of proteoglycan 
synthesis from 45% to 77% of control values (p<0.01). We next 
performed experiments to determine whether these "catabolic ef- 
fects" of PGE2 were due to signaling via EP4 receptor, which we 
showed to be upregulated in OA chondrocytes. Addition of EP4 
specific antagonist A23858 (10uM): a) reversed the capacity of 
exogenous PGE2 to inhibit proteoglycan synthesis, b) inhibited 
PGE2 dependent production of MMP-13, and c) blocked the ef- 
fects of endogenously produced PGE2, attenuating the capacity 
of IL-1 to inhibit proteoglycan synthesis. 
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Conclusion: Prostaglandin E2, the predominant eicosanoid pro- 
duced by OA chondrocytes, exerts catabolic effects within carti- 
lage. These deleterious effects require signaling via the EP4 re- 
ceptor, which should be considered as a potential target for dis- 
ease modifying agents in OA. 
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Study Aims: We report here the existence of a novel posttrans- 
lational processing pathway for lubricin in synovial lining cells, 
and show opposed regulation of glycosylation and aggregation 
by growth factors (TGFb) and cytokines (IL6 and LIF) involved in 
post-injury joint disease. 
Histological and cellular changes to the synovial lining are fre- 
quently reported in both animal models and human OA. While 
synovial histopathology is well described, very little is known 
about the pathway that links cellular changes in this tissue to 
degradation and remodeling of joint tissues which is a hallmark 
of late stage OA. A major function of the synovial lining cell is the 
secretion of macromolecular components of the joint fluid, such 
as hyaluronan (HA) and lubricin (LB). We report here novel obser- 
vations on the effect of OA-relevant cytokines on the biosynthesis 
and assembly of lubricin multimers. 
Methods: Synovial membranes from bovine metacarpalpha- 
langeal joints, were digested in collagenaseP (0.1%). Tissue rem- 
nants were removed with a cell sieve, cells washed and plated 
at lx106 cells/100 mm dish in DMEM/20% FCS. Following 1 
passage, confluent cells were supplemented for 48 h with and 
without TGFb alone and in combination with LIE Conditioned 
media fractionated by MonoQ ion exchange and separated iso- 
forms of lubricin were further analyzed by Agarose GE and 
Westerns with anti-peptide antibodies (JSCIQQ and JSCLPN) to 
the N-terminal (19-1QQVSSQ DLSC) and the C-terminal (1345- 
LPNVVTSAISLPNIRKPD) sequences. 
Results: AGE analyses of native and reduced/alkylated prepa- 
rations showed that control cultures secreted lubricin as both, 
monomers and disulfide-bonded aggregates. TGF-b caused a 
marked increase in the production of lubricin, predominantly as 
a monomeric low-charge glycoform much of which lacked the N- 
terminal epitope IQQ. When cultures were exposed to LIF, a 'shift' 
back to the 'control' culture condition occurred with synthesis of 
the low charge glycoform reduced, and less N-terminal epitope 
loss. To examine the effect of LIF on lubricin organization in the 
cell-associated matrix, cytokine-treated cell layers were fixed in 
Histochoice and examined by confocal IHC. The control cultures 
showed intense staining of the ECM domain closely associated 
with the cells. Treatment with TGF-b resulted in a marked re- 
organization of LB staining with very few intense ECM-positive 
cells remaining, most cells showed only a diffuse staining which 
appeared to be intracellular. When LIF was added at the same 
time as TGF-b the LB-positive cells now displayed the intense 
cell-associated ECM typical of control untreated cells, support- 
ing the idea that LIF can restore the 'mature secretory' synovial 
phenotype in a post-injury joint. An investigation of the signaling 
pathway for this LIF-mediated effect suggests that it involves an 
intracellular response of SOCS1. 
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Aim of Study: Heme oxygenase-1 (HO-1) is induced as an adap- 
tive mechanism against tissue injury. We have recently demon- 
strated that basal expression of HO-1 in human osteoarthritis 
(OA) chondrocytes is negatively regulated by inflammatory cy- 
tokines. In this study we have investigated whether the modula- 
tion of the HO-1 pathway could be able to attenuate the effects of 
OA. 
Methods: We have treated human OA chondrocytes with a HO-1 
inducer, cobalt protoporphyrin IX (CoPP), or with a CO donor, tri- 
carbonyldichlororuthenium (11) (TCCT) and assessed different OA 
markers in chondrocytes timulated with IL-11~. Cartilage speci- 
mens were obtained from 17 patients with diagnosis of advanced 
OA undergoing total knee joint replacement. Chondrocytes were 
used in primary culture. Cells were treated with 100 U/ml I L-11~, 
and 10 I~M CoPP or 100 I~M TCCT for24 h. 
Results: CoPP, and interestingly TCCT, significantly increased 
HO-lexpression in non-treated and IL-11~ stimulated chondro- 
cytes versus basal chondrocytes. Both drugs decreased the pro- 
duction of different inflammatory mediators (IL-6, TNF~, NO, 
PGE2), and IL-10. We have evaluated some markers of cell cy- 
cle arrest, apoptosis induction, and phenotype changes. TCCT 
was able to down-regulate p21 and Bax protein expression. Treat- 
ment with this agent resulted in a lower number of cells with DNA 
fragmentation and absence of droplets in cytoplasm in compari- 
son with control cells stimulated with IL-11~. In studies of cartilage 
degradation, CoPP was able to reduce proteoglycan degradation 
in OA explants, whereas TCCT down-regulated IGFBP-3 expres- 
sion in chondrocytes timulated with IL-11~, which may be related 
to a lower catabolism of cartilage matrix molecules. 
Conclusions: These results suggest a correlation between HO- 
land the reduction of tissue damage in human OA chondrocytes 
and support a protective role for HO-1 in OA. 
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Aim: IGF-I and OP-1 are key anabolic factors in adult articular 
cartilage. Recent studies have shown that bFGF is released from 
the adult cartilage matrix upon cartilage injury and mechanical 
stimulation. The aim of this study was to determine the effects 
of bFGF on chondrocyte proliferation and matrix synthesis in the 
presence of IGF-I and OP-1. 
Methods: Human articular chondrocytes were isolated from nor- 
mal ankle cartilage obtained from 9 tissue donors with ages of 
47-73 years. Cells were cultured in alginate beads or as carti- 
lage explants in serum-free media supplemented with mini-ITS 
with or without IGF-1 (100ng/ml), OP-1 (100ng/ml) or bFGF (0- 
100ng/ml). The cells and their pericellular matrix were visualized 
with the particle exclusion assay. Cell survival (LIVE-DEAD Cell 
Assay), proliferation (DNA levels), proteoglycan synthesis (sulfate 
incorporation), and total proteoglycan accumulation (DMB dye 
binding assay) were measured after 21 days of culture in algi- 
